Persist AI specializes in building and optimizing long-acting injectable formulations, offering high-throughput formulation screening, automated drug release testing, method transfer and manufacturing scale-up. This helps drug manufacturers solve problems with drug clearance in the body, formulation instability, acute toxicity, shelf life and many other drug formulation related problems.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
08/04/23 | $4,000,000 |
2048 Ventures Fellows Fund InnoSpark Ventures Pioneer Fund Y Combinator | undisclosed |